- Home
- STFS vs DXR Comparison
STFS vs DXR Comparison
Compare STFS & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STFS
- DXR
- Stock Information
- Founded
- STFS 2015
- DXR 1970
- Country
- STFS China
- DXR United States
- Employees
- STFS N/A
- DXR N/A
- Industry
- STFS
- DXR Medical/Dental Instruments
- Sector
- STFS
- DXR Health Care
- Exchange
- STFS NYSE
- DXR Nasdaq
- Market Cap
- STFS 49.0M
- DXR 42.6M
- IPO Year
- STFS 2024
- DXR N/A
- Fundamental
- Price
- STFS $4.47
- DXR $9.01
- Analyst Decision
- STFS
- DXR Strong Buy
- Analyst Count
- STFS 0
- DXR 1
- Target Price
- STFS N/A
- DXR $24.75
- AVG Volume (30 Days)
- STFS 326.5K
- DXR 7.6K
- Earning Date
- STFS 11-26-2024
- DXR 01-01-0001
- Dividend Yield
- STFS N/A
- DXR N/A
- EPS Growth
- STFS 43.59
- DXR N/A
- EPS
- STFS 0.15
- DXR 0.35
- Revenue
- STFS $14,972,726.00
- DXR $154,205.00
- Revenue This Year
- STFS N/A
- DXR N/A
- Revenue Next Year
- STFS N/A
- DXR N/A
- P/E Ratio
- STFS $29.00
- DXR $25.85
- Revenue Growth
- STFS 57.60
- DXR N/A
- 52 Week Low
- STFS $2.82
- DXR $7.11
- 52 Week High
- STFS $4.60
- DXR $10.04
- Technical
- Relative Strength Index (RSI)
- STFS N/A
- DXR 49.80
- Support Level
- STFS N/A
- DXR $8.53
- Resistance Level
- STFS N/A
- DXR $9.10
- Average True Range (ATR)
- STFS 0.00
- DXR 0.47
- MACD
- STFS 0.00
- DXR -0.01
- Stochastic Oscillator
- STFS 0.00
- DXR 35.71
About STFS STAR FASHION CULTURE HOLDINGS LIMITED
Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. It offer services focusing on (i) marketing campaign planning and execution; (ii) offline advertising services; and (iii) online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.